Approval · Notice of Compliance 15652 · 2014
TRAVASOL E: Notice of Compliance 15652
Issued May 29, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15652
- Date
- May 29, 2014
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph
- Therapeutic class
- Intravenous nutritive supplements
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRAVASOL E | Not yet assigned | — |
| TRAVASOL (BLEND B) | Not yet assigned | — |
| TRAVASOL (BLEND C) | Not yet assigned | — |
Medicinal ingredients
- ALANINE 2.08 G per 100ML
- ARGININE 1.04 G per 100ML
- GLYCINE 2.08 G per 100ML
- HISTIDINE 440 MG per 100ML
- ISOLEUCINE 480 MG per 100ML
- LEUCINE 620 MG per 100ML
- MAGNESIUM CHLORIDE 102 MG per 100ML
- METHIONINE 580 MG per 100ML
- PHENYLALANINE 620 MG per 100ML
- PROLINE 420 MG per 100ML
- POTASSIUM PHOSPHATE DIBASIC 522 MG per 100ML
- SODIUM ACETATE 680 MG per 100ML
- SODIUM CHLORIDE 117 MG per 100ML
- THREONINE 420 MG per 100ML
- TRYPTOPHAN 180 MG per 100ML
- TYROSINE 40 MG per 100ML
- VALINE 460 MG per 100ML
- L-LYSINE 580 MG per 100ML
- L-ALANINE 2.08 G per 100ML
- L-LYSINE HCL 580 MG per 100ML
- L-ALANINE 2.07 G per 100ML
- ARGININE 1.15 G per 100ML
- GLYCINE 1.03 G per 100ML
- HISTIDINE 480 MG per 100ML
- ISOLEUCINE 600 MG per 100ML
- LEUCINE 730 MG per 100ML
- METHIONINE 400 MG per 100ML
- PHENYLALANINE 560 MG per 100ML
- PROLINE 680 MG per 100ML
- SERINE 500 MG per 100ML
- VALINE 580 MG per 100ML